{"id":556,"date":"2021-01-11T06:54:25","date_gmt":"2021-01-11T06:54:25","guid":{"rendered":"http:\/\/events.marketsandmarkets.com\/blog\/?p=556"},"modified":"2021-01-11T06:54:25","modified_gmt":"2021-01-11T06:54:25","slug":"julie-schwedock-from-takeda-pharmaceuticals-speaks-about-lbps-what-to-consider-when-choosing-cdmos","status":"publish","type":"post","link":"https:\/\/events.marketsandmarkets.com\/blognew\/julie-schwedock-from-takeda-pharmaceuticals-speaks-about-lbps-what-to-consider-when-choosing-cdmos\/","title":{"rendered":"Julie Schwedock from Takeda Pharmaceuticals speaks about LBPs: What to consider when choosing CDMOs."},"content":{"rendered":"\n

Julie Schwedock<\/strong>, PhD is Associate Director of the\nMicrobial Development Team at Takeda Pharmaceuticals.  She leads a\ncross-functional Pharmaceutical Sciences team for Live Bacterial Products\n(LBPs) focused on treating dysbiosis of the gut microbiome.  She also\nheads a functional line group that works on process development for microbial\nexpression systems as well as LPBs.  Prior to that she was Associate\nDirector of Analytical Development and QC at Vedanta Biosciences, also working\nwith LBPs, where she developed analytics in an uncertain regulatory landscape\nfor a product now in Ph2 clinical trials.  She was the Director of\nMicrobiology R&D at Rapid Micro Biosystems, Inc., a company whose mission\nis to develop rapid microbiological techniques for pharma and food\nmicrobiology.  And she also worked at Genomic Profiling Systems, a company\nwhose mission was to develop rapid diagnostics for infectious disease. \nShe received her Ph.D. from Stanford University, and her B.S. from MIT.<\/p>\n\n\n\n

We\ninterviewed Julie about her thoughts on the newfound role of human microbiomes.\nNew research and advances in the field, her presentation at the Conference and\nher take on the conference program.   <\/p>\n\n\n\n

Question: <\/strong>How\nis human microbiome a new protagonist in managing human\nhealth<\/a>?<\/strong><\/p>\n\n\n\n

Julie Schwedock<\/strong>:<\/strong><\/p>\n\n\n\n

Our understanding of the human microbiome and its\naffect on human health is just beginning.  In the not-to-distant future,\nLBPs will be an important part of medicine: restoring health and treating\nchronic conditions.  In addition, we will have a better understanding of\nhow what we eat, the products we use, and how we live all affect our microbiome\nand how that in turn affects our health.<\/p>\n\n\n\n

Question: <\/strong>What\nare the challenges of preserving and not preserving live probiotics?<\/strong><\/p>\n\n\n\n

Julie Schwedock<\/strong>:<\/strong><\/p>\n\n\n\n

The challenges of preserving live probiotics are in\nformulation, packaging, and storage conditions.  In an ideal world, room\ntemperature storage might suffice, but for the short-term, some products may\nrequire refrigeration until formulations and packaging are improved.<\/strong><\/p>\n\n\n\n

Question:<\/strong>\nHaving gone through the agenda, what are your views on it and how helpful is it\nto the targeted audience?<\/strong><\/p>\n\n\n\n

Julie Schwedock<\/strong>:<\/strong><\/p>\n\n\n\n

The\nMarketsandMarkets Virtual\nConference 3rd<\/sup> Edition Gen Next Probiotics and Microbiome will\naddress how the microbiome interacts with our health, and how companies can\ncreate commercially viable LBPs.<\/p>\n\n\n\n

Julie Schwedock <\/strong>is one of the speakers at our 3rd Edition Marketsandmarkets Next Gen Microbiome and Probiotics- Virtual Conference<\/strong><\/a> being held on February 25th -26<\/strong>th<\/strong><\/sup>, 2021<\/strong>. She will be presenting on the Day 1 of the conference on the topic \u2013 \u2018LBPs: What to consider when choosing CDMOs; When choosing a CDMO for your live biotherapeutics, what are the important aspects that a company should consider?\u2019<\/strong><\/p>\n\n\n\n

To Know more about her presentation, visit our website \u2013 <\/a>https:\/\/bit.ly\/2X8h7DX<\/a><\/p>\n\n\n\n

If you wish to learn a great deal from her\nabout the Microbiome Industry, then register online<\/a> or email aradhna.robert@marketsandmarkets.com<\/a> to book your slot at the conference.<\/p>\n","protected":false},"excerpt":{"rendered":"

Julie Schwedock, PhD is Associate Director of the Microbial Development Team at Takeda Pharmaceuticals.  She leads a cross-functional Pharmaceutical Sciences team for Live Bacterial Products (LBPs) focused on treating dysbiosis of the gut microbiome.  She also heads a functional line group that works on process development for microbial expression systems as well as LPBs.  Prior […]<\/p>\n","protected":false},"author":2,"featured_media":562,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"inline_featured_image":false,"_mi_skip_tracking":false},"categories":[3,2],"tags":[136,85,231,113,212,81,98,166,165,232],"_links":{"self":[{"href":"https:\/\/events.marketsandmarkets.com\/blognew\/wp-json\/wp\/v2\/posts\/556"}],"collection":[{"href":"https:\/\/events.marketsandmarkets.com\/blognew\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/events.marketsandmarkets.com\/blognew\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/events.marketsandmarkets.com\/blognew\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/events.marketsandmarkets.com\/blognew\/wp-json\/wp\/v2\/comments?post=556"}],"version-history":[{"count":4,"href":"https:\/\/events.marketsandmarkets.com\/blognew\/wp-json\/wp\/v2\/posts\/556\/revisions"}],"predecessor-version":[{"id":563,"href":"https:\/\/events.marketsandmarkets.com\/blognew\/wp-json\/wp\/v2\/posts\/556\/revisions\/563"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/events.marketsandmarkets.com\/blognew\/wp-json\/wp\/v2\/media\/562"}],"wp:attachment":[{"href":"https:\/\/events.marketsandmarkets.com\/blognew\/wp-json\/wp\/v2\/media?parent=556"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/events.marketsandmarkets.com\/blognew\/wp-json\/wp\/v2\/categories?post=556"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/events.marketsandmarkets.com\/blognew\/wp-json\/wp\/v2\/tags?post=556"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}